等待開盤 11-19 09:30:00 美东时间
+0.430
+1.29%
Immunovant reports positive trial results for IMVT-1402 in rheumatoid arthritis and plans FDA discussions on a registrational pathway.
11-10 01:23
https://www.sec.gov/Archives/edgar/data/1764013/000176401326000124/imvt-formsx3asr2026v1.htm
11-09 20:50
KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX report before the
11-09 04:31
Immunovant halts IMVT-1402 CLE trial after missing primary endpoints, driving IMVT and Roivant shares down in premarket trading.
09-23 21:03
Immunovant Inc (NASDAQ: IMVT) shares are trading higher Wednesday despite posting a wider-than-expected fourth‑quarter loss.
05-21 01:09
US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe's Companies reported upbeat earnings.
05-21 00:16
Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.60) by 21.67 percent. This is a 14.06 percent decrease over losses of $(0.64) per share from the
05-20 19:01
GSAT: 24% | Globalstar shares are trading higher following reports suggesting that Amazon is in discussions to acquire the company. IMVT: -17% | Immunovant shares are trading lower after the company
04-02 19:17
Immunovant (NASDAQ:IMVT) announced its Q3 earnings on Friday, February 6, 2026 ...
02-06 20:02
Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
2025-12-12 02:39